This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Novartis Ag, Vicuron Holdings LLC, Vicuron Pharmaceuticals Inc.. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Morristown, NJ (US) (2008)
- Swampscott, MA (US) (2009 - 2011)
Company Filing History:
2 out of 3,978 
1 out of 1 
1 out of 23 Years Active: 2008-2011
Title: Kathryn Rene Bracken: Innovator in Antimicrobial Compounds
Introduction
Kathryn Rene Bracken is a distinguished inventor based in Swampscott, MA (US), known for her significant contributions to the field of antimicrobial compounds. With a total of three patents to her name, she has made remarkable strides in the development of novel compounds that have the potential to combat bacterial infections.
Latest Patents
Her latest patents focus on N-formyl hydroxylamine compounds, which are characterized by their ability to inhibit peptidyl deformylase (PDF), an enzyme found in prokaryotes. These innovative compounds not only serve as antimicrobials and antibiotics but also demonstrate selective inhibition of PDF compared to other metalloproteinases, such as MMPs. The methods of preparation and application of these compounds are also detailed in her patents.
Career Highlights
Throughout her career, Kathryn has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Vicuron Pharmaceuticals Inc. Her work has been instrumental in advancing the understanding and application of antimicrobial agents.
Collaborations
Kathryn has collaborated with notable professionals in her field, including Simon Bushell and Karl Dean. These partnerships have further enriched her research and development efforts, leading to innovative solutions in antimicrobial therapies.
Conclusion
Kathryn Rene Bracken's contributions to the field of antimicrobial compounds highlight her
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile